Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Aduro BioTech, Inc. - Product Pipeline Review - 2015

Published: Feb-2015 | Format: PDF | Global Markets Direct | Number of pages: 38 | Code: MRS - 7040

 

Global Markets Direct’s, ‘Aduro BioTech, Inc. Product Pipeline Review 2015’, provides an overview of the Aduro BioTech, Inc.’s pharmaceutical research and development focus.

 

This report provides comprehensive information on the current therapeutic developmental pipeline of Aduro BioTech, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Scope

 

The report provides brief overview of Aduro BioTech, Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Aduro BioTech, Inc.’s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement 
Latest news and deals relating to the Aduro BioTech, Inc.’s pipeline products

 

Reasons to buy

 

Evaluate Aduro BioTech, Inc.’s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Aduro BioTech, Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Aduro BioTech, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Aduro BioTech, Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aduro BioTech, Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Aduro BioTech, Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table of Contents
 

Table of Contents 2
List of Tables 4
List of Figures 4
Aduro BioTech, Inc. Snapshot 5
Aduro BioTech, Inc. Overview 5
Key Information 5
Key Facts 5
Aduro BioTech, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Aduro BioTech, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
Aduro BioTech, Inc. - Pipeline Products Glance 12
Aduro BioTech, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Aduro BioTech, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Aduro BioTech, Inc. - Drug Profiles 15
Cell Therapy to Target GM-CSFR for Pancreatic Cancer 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
CRS-207 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ADU-623 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Cell Therapy to Target GM-CSFR for Melanoma 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ADU-214 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
ADUS-100 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
anthrax vaccine 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecules for Oncology 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
STINGVAX 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Vaccines for Oncology 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Aduro BioTech, Inc. - Pipeline Analysis 28
Aduro BioTech, Inc. - Pipeline Products by Target 28
Aduro BioTech, Inc. - Pipeline Products by Route of Administration 29
Aduro BioTech, Inc. - Pipeline Products by Molecule Type 30
Aduro BioTech, Inc. - Recent Pipeline Updates 31
Aduro BioTech, Inc. - Dormant Projects 35
Aduro BioTech, Inc. - Locations And Subsidiaries 36
Head Office 36

 

Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 37
Disclaimer 38


List of Tables
 

Aduro BioTech, Inc., Key Information 5
Aduro BioTech, Inc., Key Facts 5
Aduro BioTech, Inc. - Pipeline by Indication, 2015 7
Aduro BioTech, Inc. - Pipeline by Stage of Development, 2015 8
Aduro BioTech, Inc. - Monotherapy Products in Pipeline, 2015 9
Aduro BioTech, Inc. - Out-Licensed Products in Pipeline, 2015 10
Aduro BioTech, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015 11
Aduro BioTech, Inc. - Phase II, 2015 12
Aduro BioTech, Inc. - Phase I, 2015 13
Aduro BioTech, Inc. - Preclinical, 2015 14
Aduro BioTech, Inc. - Pipeline by Target, 2015 28
Aduro BioTech, Inc. - Pipeline by Route of Administration, 2015 29
Aduro BioTech, Inc. - Pipeline by Molecule Type, 2015 30
Aduro BioTech, Inc. - Recent Pipeline Updates, 2015 31
Aduro BioTech, Inc. - Dormant Developmental Projects,2015 35


List of Figures
 

Aduro BioTech, Inc. - Pipeline by Top 10 Indication, 2015 7
Aduro BioTech, Inc. - Pipeline by Stage of Development, 2015 8
Aduro BioTech, Inc. - Monotherapy Products in Pipeline, 2015 9
Aduro BioTech, Inc. - Pipeline by Top 10 Target, 2015 28
Aduro BioTech, Inc. - Pipeline by Top 10 Route of Administration, 2015 29
Aduro BioTech, Inc. - Pipeline by Top 10 Molecule Type, 2015 30

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing